Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Hemosphere
company
About
Hemosphere is a commercial medical device company specialized in vascular access for patients on dialysis.
- 501 - 1000
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $9.30M
- Industries
- Health Care,Medical Device
- Founded date
- Jan 1, 1998
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$9.30M
Hemosphere has raised a total of
$9.30M
in funding over 2 rounds. Their latest funding was raised on
Apr 7, 2010 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 7, 2010 | Series A | $9.30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Hemosphere is funded by 1 investors.
Cutlass Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Cutlass Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
